Guolin Yuan

1.5k total citations
43 papers, 847 citations indexed

About

Guolin Yuan is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Guolin Yuan has authored 43 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Hematology and 9 papers in Oncology. Recurrent topics in Guolin Yuan's work include Advanced biosensing and bioanalysis techniques (13 papers), Electrochemical sensors and biosensors (8 papers) and Multiple Myeloma Research and Treatments (6 papers). Guolin Yuan is often cited by papers focused on Advanced biosensing and bioanalysis techniques (13 papers), Electrochemical sensors and biosensors (8 papers) and Multiple Myeloma Research and Treatments (6 papers). Guolin Yuan collaborates with scholars based in China, Taiwan and United Kingdom. Guolin Yuan's co-authors include Zhichao Chen, Qiubai Li, Hongxiang Wang, Chao Yu, Robert Peter Gale, Wenlan Chen, Xiaoting Lu, Yanling Ma, Li Chen and Wenjuan He and has published in prestigious journals such as Blood, Analytical Chemistry and Scientific Reports.

In The Last Decade

Guolin Yuan

42 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guolin Yuan China 15 336 298 242 147 104 43 847
Xian Zhang China 13 239 0.7× 460 1.5× 356 1.5× 51 0.3× 63 0.6× 54 971
Shujie Wang China 21 303 0.9× 202 0.7× 82 0.3× 238 1.6× 29 0.3× 116 1.4k
Michael Dürr Germany 21 175 0.5× 144 0.5× 124 0.5× 55 0.4× 79 0.8× 50 1.2k
Shuang Qi China 15 163 0.5× 144 0.5× 182 0.8× 31 0.2× 68 0.7× 56 751
Yoon Ji Choi South Korea 18 251 0.7× 456 1.5× 44 0.2× 36 0.2× 97 0.9× 111 1.1k
Ashley Rosko United States 20 461 1.4× 713 2.4× 38 0.2× 584 4.0× 38 0.4× 122 1.4k
Haluk Özen Türkiye 25 433 1.3× 206 0.7× 48 0.2× 75 0.5× 117 1.1× 76 1.8k
Hisako Hashimoto Japan 30 117 0.3× 179 0.6× 121 0.5× 159 1.1× 12 0.1× 146 2.4k
Jiaxi Chen China 17 168 0.5× 161 0.5× 49 0.2× 37 0.3× 105 1.0× 54 739
Tri Tran United States 19 209 0.6× 82 0.3× 217 0.9× 234 1.6× 12 0.1× 35 1.2k

Countries citing papers authored by Guolin Yuan

Since Specialization
Citations

This map shows the geographic impact of Guolin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guolin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guolin Yuan more than expected).

Fields of papers citing papers by Guolin Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guolin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guolin Yuan. The network helps show where Guolin Yuan may publish in the future.

Co-authorship network of co-authors of Guolin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Guolin Yuan. A scholar is included among the top collaborators of Guolin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guolin Yuan. Guolin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Xuelian, Beibei Chen, Man He, Guolin Yuan, & Bin Hu. (2025). Facile Cascaded Negative Magnetophoresis Chip Combined with ICP–MS for Efficient Sorting and Online Detection of Circulating Tumor Cells. Analytical Chemistry. 97(12). 6702–6710. 5 indexed citations
2.
Xu, Yan, Beibei Chen, Man He, Guolin Yuan, & Bin Hu. (2024). Dual-Amplification Single-Particle ICP-MS Strategy Based on Strand Displacement Amplification–CRISPR/Cas12a Amplification for Homogeneous Detection of miRNA. Analytical Chemistry. 97(1). 811–817. 14 indexed citations
3.
Xu, Min, Jing-Ming Guo, Yuping Gong, et al.. (2024). Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study. The Lancet Regional Health - Western Pacific. 47. 101096–101096. 1 indexed citations
5.
Cheng, Fang, Guolin Yuan, Qiang Li, Zheng Cui, & Wei‐Ming Li. (2023). Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China. Frontiers in Oncology. 13. 1172910–1172910. 6 indexed citations
7.
Yuan, Guolin, et al.. (2022). Non-targeted metabonomic analysis of plasma in patients with atherosclerosis by liquid chromatography-mass spectrometry. Annals of Translational Medicine. 10(3). 133–133. 10 indexed citations
8.
Xie, Fei, et al.. (2022). Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling. Frontiers in Cardiovascular Medicine. 9. 895916–895916. 23 indexed citations
9.
Liu, Wen, Xiaoying Zhu, Ling Tang, et al.. (2022). ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1/p53/p21 pathway. Scientific Reports. 12(1). 17990–17990. 10 indexed citations
10.
Jiang, Hongqiang, Yanxia Jin, Yufeng Shang, et al.. (2021). Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency. Frontiers in Medicine. 8. 762419–762419. 2 indexed citations
11.
Li, Wei‐Ming, Guolin Yuan, Zhuangzhi Yang, et al.. (2020). COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 34(7). 1799–1804. 56 indexed citations
12.
Li, Wen‐Cui, et al.. (2020). Effects of small nucleolar RNA SNORD44 on the proliferation, apoptosis and invasion of glioma cells. Histochemistry and Cell Biology. 153(4). 257–269. 17 indexed citations
13.
Jin, Yanxia, Yufeng Shang, Lu Ding, et al.. (2019). <p>A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas</p>. OncoTargets and Therapy. Volume 12. 10587–10596. 3 indexed citations
14.
Shen, Na, Qing Li, Yong You, et al.. (2019). <p>Tumor necrosis factor &alpha; knockout impaired tumorigenesis in chronic myeloid leukemia cells partly by metabolism modification and miRNA regulation</p>. OncoTargets and Therapy. Volume 12. 2355–2364. 9 indexed citations
15.
Zhang, Liming, Qian Lei, Hongxiang Wang, et al.. (2018). Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease. Theranostics. 9(1). 196–209. 55 indexed citations
17.
Yuan, Guolin, et al.. (2015). Ultrasensitive electrochemical detection of secretoneurin based on Pb2+-decorated reduced graphene oxide–tetraethylene pentamine as a label. Biosensors and Bioelectronics. 69. 95–99. 10 indexed citations
18.
Zhang, Liming, Hongxiang Wang, Guolin Yuan, et al.. (2015). Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis. Experimental and Therapeutic Medicine. 10(6). 2093–2101. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026